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Abstract.  During skeletal development, chondrocytes 
go through several stages of differentiation. The last 
stage, chondrocyte hypertrophy, occurs in areas of en- 
dochondral ossification. Mature hypertrophic chondro- 
cytes differ from immature chondrocytes in that they 
become postmitotic, increase their cellular volume up 
to eightfold, and synthesize a unique set of matrix 
molecules. One such molecule is a short collagenous 
protein, collagen X. Previous studies have shown that 
collagen X  is not expressed by other cell types and 
that its  specific expression in hypertrophic chondro- 
cytes is controlled by transcriptional mechanisms. To 
define these mechanisms, plasmid constructs contain- 
ing the chicken collagen X gene promoter and 5' flank- 
ing regions fused to a reporter gene (chloramphenicol 
acetyl transferase, CAT) were transfected into primary 
cultures of collagen X-expressing and nonexpressing 
cells. A construct containing a short (558 bp) pro- 
moter exhibited high levels of CAT activity in all cell 
types (fibroblasts, immature, and hypertrophic chondro- 
cytes). Adding a 4.2-kb fragment of 5' flanking DNA ~ 
to this construct resulted in a dramatic reduction of 
CAT activity in fibroblasts and immature chondrocytes, 
but had no effect in hypertrophic chondrocytes. Addi- 
tion of three subfragments of the 4.2-kb fragment to 
the initial construct, either individually or in various 
combinations, showed that all subfragments reduced 
CAT activity somewhat in non-collagen X-expressing 
cells, and that their effects were additive. Unrelated 
DNA had no effect on CAT activity. The results sug- 
gest that multiple, diffuse upstream negative regulatory 
elements act in an additive manner to restrict transcrip- 
tion of the collagen X gene to hypertrophic chondro- 
cytes. 
T 
IfF transition  from cartilage  to bone during skeletal 
development  is  a  multi-step  process involving car- 
tilage  synthesis,  hypertrophy,  calcification,  degrada- 
tion, and replacement of cartilage by bone and marrow. The 
primary growth plate of developing long bones, located be- 
tween the epiphyseal  cartilage  and the bone of the meta- 
physis, offers an excellent display of this sequence of events 
as it relates to cell differentiation (Poole, 1991). The reserve, 
or resting zone, just adjacent to the epiphyseal cartilage, con- 
sists of nondividing,  small, spherical cells. These cells give 
rise to proliferating  chondrocytes which appear as flattened 
cells stacked in columns within the proliferating zone. These 
chondrocytes become round and enlarge into hypertrophic 
chondrocytes  within the zone of maturation. The cells finally 
enter the upper and lower hypertrophic zones, the latter be- 
ing distinguished from the former by the presence of calcify- 
ing zones of cartilage. The entire differentiation-maturation 
process of a single cell takes ~3 d (Poole, 1991). Permanent 
cartilage, which does not undergo endochondral ossification, 
contains small, round chondrocytes  which produce the com- 
ponents of cartilage matrix, particularly type II collagen and 
aggrecan. In contrast, hypertrophic chondrocytes  selectively 
synthesize collagen X, and thus cartilage which is undergo- 
ing endochondral ossification can be distinguished  by the 
presence of hypertrophic chondrocytes  and their unique col- 
lagen X product (Gibson et al.,  1984; Schmid and Linsen- 
mayer 1985a,b). 
Collagen  X,  secreted by hypertrophic chondrocytes,  is 
localized pericellularly in a capsule-like  structure (Gibson 
et al., 1986; Haynes, 1990; Schmid and Linsenmayer, 1990; 
Lu Valle et al., 1992). It is also found in the extracellular ma- 
trix in the vicinity of collagen H-containing fibrils (Poole 
and Pidoux,  1989; Schmid and Linsenmayer,  1990). The 
hypertrophic chondrocyte-specific transcriptional  activation 
of the collagen X gene (Castagnola et al., 1988; Lu Valle et 
al.,  1989, 1992) is accompanied by decreases in the levels 
of both collagen IX mRNA (Linsenmayer et al.,  1991) and 
collagen II mRNA (Oshima  et al.,  1989; Lu Valle et al., 
1992). In fact, type collagen X constitutes '~45 % of  the total 
collagen produced by  mature hypertrophic chondrocytes 
(Reginato et al.,  1986), and therefore is a major secreted 
protein product of this cell type. 
The chick embryonic sternum is an excellent tissue model 
in which to study the cell-specific control of collagen X gene 
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undergo endochondral ossification  at  embryonic day  16, 
when chondrocyte  hypertrophy and collagen X gene expres- 
sion are first observed (Gibson and Flint,  1985; Lu Valle et 
al., 1992). The caudal portion does not undergo endochon- 
dral ossification during embryonic and early postnatal devel- 
opment (Fell,  1956), but will ossify in the adult chicken. 
Chondrocytes isolated from the cephalic portion of sterna af- 
ter embryonic day 16 are large in size and actively synthesize 
collagen  X in culture.  In contrast, chondrocytes from the 
caudal region at the same embryonic stage are initially small 
in size and do not synthesize collagen X; however, over a 
period of 2-5 wk in culture, these ceils undergo maturation 
and develop into hypertrophic,  collagen X-producing cells 
(Solursh et al., 1986; Castagnola et al., 1987; Pacifici et al., 
1991a). 
We wished to investigate the mechanisms by which the 
cell-specific transcriptional activation of  the collagen X gene 
in  hypertrophic chondrocytes is  achieved.  To  determine 
which portions  of the gene are involved in hypertrophic 
chondroeyte-specific promoter activity, we used a 5,300-bp 
DNA fragment which includes the first intron and extends 
5' in the chicken collagen X genomic clone (Lu Valle et al., 
1988) to prepare collagen X promoter-reporter gene con- 
structs. The reporter gene used in these constructs was the 
bacterial  chloramphenicol acetyl transferase  gene (CAT)  1 
(Gorman et al., 1982). By introducing collagen X promoter- 
CAT constructs into primary cultures  of chick embryonic 
collagen X-expressing hypertrophic chondrocytes (HC) and 
non-expressing immature chondrocytes (IC) and fibroblasts 
(CEF), we found that a 640-bp fragment containing the type 
X collagen transcription start site directed high levels of  CAT 
activity in all cell types. Hypertrophic chondrocyte-specific 
transcriptional  activity  was generated by the presence of 
multiple negative regulatory dements within 4,200 bp up- 
stream of the 640-bp  fragment. These negative elements, 
when present together, reduced promoter activity by ~90 % 
in non-type X collagen expressing cells, but had no signifi- 
cant effect on activity in hypertrophic chondrocytes. 
Materials and Methods 
Cell Culture, Immunocytochemistry, and Transfection 
HC and IC were isolated from the upper one third and the lower one third 
of chick embryonic day 18 sterna, respectively, by digestion of minced tis- 
sue in 1.5 mg/mi collngenase type I (Sigma Immunochemicals, St. Louis, 
MO) and 0.1% trypsin (GIBCO BRL, Gaithersburg, MD) in DME for 1 h 
at 37°C.  This first digestion removes  perichondrial flbroblasts.  This was 
followed by removal of the medium, addition of more medium containing 
the same concentrations of enzymes, and incubation for an additional 2 h. 
Cells were filtered  through Nytex,  rinsed in DME containing 10% FCS 
(Hyclone  Labs, Logan,  liT), and plated at 3  x  105 cells/ml of high glu- 
cose DME containing 10% FCS and 50 U/mi penicillin and streptomycin 
(complete medium). Chondrocytes were maintained in primary culture for 
3-7 d before transfection.  CEF were obtained by digestion of tendon or skin 
from day 12-19 embryos with trypsin/collagenase  as above in DME for 30 
rain. Resultant cells were plated at 1 ×  10  ~ ceUs/ml in the same medium 
as above. 
Cells were processed for immunofluorescence  as described (Pacilici  et 
1. Abbreviations used in this paper: CAT, chloramphenicol acetyl transfer- 
ase; CEF,  chick embryonic fibroblasts;  HC,  hypertrophic chondrocytes; 
HSV, herpes simplex virus; IC, immature chondrocytes. 
al.,  1983). The antiserum used in these assays has been demonstrated to 
be specifically  against chicken collagen  X (Pacifici et al.,  1991b). 
Transient transfections were performed using either a high-efficiency cal- 
cium phosphate coprecipitation method  in the presence of N,N-bis(2- 
hydroxyethyl)-2-aminoethanesulfoulc  acid (Cben and Okayama,  1987) or 
liposome-mediated  transfection  using  DOTAP  (Boehringer  Mannheim 
Corp., Indianapolis,  IN). In both cases,  choadrocytes were treated with 4 
U/ml bovine testes hyaluronidase  (Calbiochem-Novabiuebem  Corp.,  La 
Jolla, CA) during the 24 h before transfection as well as during the incuba- 
tion with DNA. We have found that this treatment, which removes pericel- 
lular proteoglycans  (Pacifici et al.,  1983), increases transfection efficiency 
four- to sixfold on the basis of either CAT activity or number of/~-galac- 
tosidase positive cells.  Each 60-ram dish of cells was cotrausfected  with 
4 ttg of the collagen  X promoter-CAT  vector constructs and 1 ~tg of the 
~-galactosidase plasmid pCHll0 (Hall et al., 1983) for a period of 8-14 h. 
The medium was then replaced and ceils were incubated for an additional 
48 h before harvest. 
Collagen X Promoter-CAT Plasmids 
The CAT vectors used for these studies were pBLCAT2, which contains the 
herpes simplex virus (HSV) thymidine kinase promoter 5' of the coding re- 
gion for  CAT  and a  polylinker 5' of the promoter,  and pBLCAT3,  a 
promoterless vector which contains a polylinker 5' of  the CAT coding region 
(Luckow  and Schutz,  1987).  These plasmids were used as positive and 
negative controls for CAT activity, respectively. Collagen X promoter frag- 
ments (see Fig. 1) were cloned into the polylinker region of  the CAT vectors, 
using restriction endonucleases (Boehringer Mannheim Corp.) and phos- 
phorylated linkers (New England Biolabs Inc., Beverly, MA). The 640-bp 
fragment, which contains the transcription start site and 558 bp of 5' flank- 
ing sequence in addition to 82 bp of the first (untranslated) exon, was ex- 
cised from the chick genomic clone PL10 (Lu Valle et ai.,  1988) using re- 
striction endonucleases HindlII and SacI. The addition of SalI linkers to the 
3' SacI site allowed the 640-bp fragment to be ligated in the correct orienta- 
tion into the HindIII and SalI sites of the polyfinker region of pBLCAT3. 
The C-640 fragment was excised from PL10 using Nsil and SacI. After the 
addition of SalI linkers,  the fragment was ligated into the SalI site of the 
polylinker in pBLCAT3 and oriented using the internal HindlII site.  The 
B fragment was excised from PL10 with PstI and NsiI, and was ligated into 
the PstI site of the polylinker of C-640 CAT. This PstI site is located just 
5' and adjacent to the SalI site in which the C-640-bp fragment was ligated. 
Since the 3' NsiI site of the B fragment is compatible for ligadon with PstI 
but does not regenerate a PstI site, digesting the resultant construct with PstI 
and Hindm (the internal site in the C-640 fragment) allowed the orientation 
of the B fragment to be determined. The A fragment, the AB fragment, and 
the ABC fragment, were all excised  from PLI0, modified  with HindiII 
linkers, and ligated into the HindIII site adjacent and 5' of the 640-bp frag- 
ment in pBLCAT3. Orientation was determined using internal restriction 
sites, except for the A fragment, which was oriented by sequence analysis. 
Unrelated DNA (3,300 bp of coding sequence from a nuclear pore complex 
protein, NP, a gift from Dr. B. Burke, Department of Cellular and Molecu- 
lar Biology, Harvard Medical School) was ligated into the HindIII site 5' 
of the 640-bp fragment in pBLCAT3 as an additional control construct. All 
plasmids were purified by polyethylene glycol precipitation (Lis,  1980) fol- 
lowed  by  cesium chloride/ethidium bromide equilibrium centrif~gation 
(Radioff et al.,  1967). 
Sequencing  was carried out as described (Lu Valle et al.,  1988) using 
the dideoxy  termination method (Sanger et el.,  1977). 
I),pe X Promoter Activity Assays 
Cells were harvested after transfection according to Gorman et al. (1982) 
and were resuspeaded in 110/d of 0.25 M Tris pH 7.8. After preparation 
of the cell lysates by three freeze/thaw cycles from ethanol/dry ice to 37°C, 
for 5 min each, and centrifngation (5 rain at 4°C at 16000 g), 40/tl of the 
extract was used in a/~-galactusidase activity assay (Herbomel et ai., 1984). 
Aliquots of cell lysate containing 5 U of/~-galactosidase  activity were used 
for CAT assays. CAT activity was determined by chromatographic assay ac- 
cording to Gorman et at. (1982), and quantitated by scintillation counting. 
Activity was calculated  as: 
cpm acetylated[14C]chloramphenicol  (1) 
cpm acetylated  +  cpm unacetylated [l~C]chloramphenicol 
Values were expressed as percent of CAT activity in cells transfected with 
640 CAT, where 640 CAT activity is 100%. Figures which display CAT ac- 
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periment  done in duplicate. Each  value  represents  the average  of  duplicate 
transfections. The range of these values is stated in the figure legends. 
Results 
Effects of  Proximal Flanking Sequences on the 
Ability of the Collagen X Promoter to Drive CAT 
Expression in HC and CEF 
Initial transfection experiments compared the promoter ac- 
tivity of both 640  CAT  (Fig.  1)  and  the positive control 
vector pBLCAT2 (Luckow and Schutz,  1987) in both col- 
lagen X-expressing HC (Fig. 2, a  and b) and non-collagen 
X-expressing CEF  (Fig.  2,  e  and f).  HC  supported high 
CAT activity regardless of  which promoter was used (Fig. 3). 
Surprisingly, both constructs elicited strong CAT activity in 
CEF as well. In both cell types, the type X collagen promoter 
exhibited an activity equivalent to or higher than that of the 
HSV thymidine kinase promoter. 
The sequence of the promoter and proximal flanking se- 
quences within the 640-bp fragment are shown in Fig. 4. 
Comparison of this sequence with consensus regulatory se- 
quence elements available from Genbank indicated that there 
are 85 possible regulatory sequence elements in this region. 
Of particular interest are enhancer consensus elements in- 
cluding the core enhancer sequence found in the rat o~l([I) 
collagen promoter at  -513 nt CKohno et al.,  1985); a con- 
sensus DNA binding site shared among homeobox proteins 
1~  I  ,~  I  ,1®  I  ~o  D  p,  ,,"  ;  , ,11  I 
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~O CAT 
II 
II 
II 
II 
II 
~CAT 
AB-640 CAT 
BC-640 CAT 
ABC-640 CAT 
Figure 1.  Collagen X promoter/CAT constructs. The collagen X 
gene is drawn schematically at the top of the figure. (n) Exons. 
640 is the 640-bp fragment containing the transcription start and 
558 bp of 5' flanking sequence. 1,100, 1,700, and 1,400 refer to the 
DNA fragments located 5' of 640 of sizes, 1,100, 1,700, and 1,400 
bp. These fragments are also called fragments C, B, and A, respec- 
tively. Collagen X promoter/CAT constructs are depicted below the 
drawing of the collagen X gene. (a) Portions of the collagen X 
promoter and upstream regions which are present in the construct; 
black lines indicate portions of the upstream region which are de- 
leted in the construct; (~) the reporter gene, CAT. 
Figure 2. Phase (a, c, and e) and immunofluorescence (b, d, and 
f) micrographs of HC, IC, and CEE Cells were grown in primary 
culture for ,,07 d and were then processed for immunoflnorescence 
using a collagen X antiserum. (a and b) HC; (c and d) IC; (e and 
f) CEE Note that only hypertrophic chondrocytes produce detect- 
able collagen X.  Bar,  140 #m. 
including yeast mating type MAT c~2 and the human oct 2 
gene product, at -367 nt (Ko et al.,  1988); two sequences 
which resemble retinoic acid-responsive elements at -346 
and -280 nt (de The et al., 1990; Sucov et al., 1990; Vasios 
et  al.,  1989);  a  human  immunoglobulin  enhancer  DNA 
binding domain at  -211 nt (Maeda et al.,  1987), which is 
likely to be a variant of the consensus sequence which is a 
potential binding site for the human oct 2 gene product; and 
an AP-2 consensus binding site at -126 nt (Imagawa et al., 
1987). 
Effects of  Distal Y Flanking Sequences on the 
Ability of the Collagen X Promoter m Drive the 
Expression of  CAT in HC, IC, and CEF 
Because transfection of 640 CAT resulted in high CAT activ- 
Figure 3.  The effects of the 
640-bp fragment on CAT ac- 
tivity  in HC and CEE  This 
figure illustrates the effect of 
the 640-bp fragment on CAT 
activity in HC and CEF, and 
compares  this  activity  with 
that  of the  positive  control 
CAT vector,  pBI~AT2. In both 
cell  types,  transfvcfion with 
either 640 CAT or pBLCAT2 
results in equivalent acetyla- 
tion of CAT, as shown by the 
density of the upper two spots 
in each lane. 
Lu Valle et al. Negative Elements Restrict Type X  Gene Expression  1175 AAGCTTAGAA ATACAACTTT GGAGACAATC 
GG~TAATC  TTCGGATTCA TATACAACTC 
ATTCTAAGCT CTCTATTTGC ACCTCAGTGA 
AGAGGAGTAC TCCTGAAAGT AACACCTCGA 
-346 
TTAGTTAAAA CGTTCACAGA AAAATCCAAA 
280 
ACCTTACTTA CAATTTTTTT CCATTTGTAA 
AGAAAGGATG CAAAAGTTTA GAAAATACGA 
TCATCAACAA GAAGAGGTCC AAGAGAAGAA 
CAGGACCTAA AATCCTACCC AAAATAGCAA 
CATATACACA CAGATAATTA CTGCTTACTG 
J 
TCAGCAGTCA CCAAACTAGG GTGAAAATCG 
÷I 
GCTTGAAATC ATCAGCTTCT GCTCACTCAC 
ACCAGAGGAG GATTTGCCAC TCTACTGCCT 
-513 
TCTGAATACA ATAACTGGT___~T  -508 
TCAAATTAAC ATCTTAACTG  -458 
ACAACTACTC ACATAATCTC  -408 
367 
AGTCGAAAAT ATGTAATTCT -358 
TGAAGCACCT AAAATTATAA -308 
CCTTTCTCAT TTCTAAAAGC -258 
-211 
AACTACAGGC AATACAATTT -208 
GAAGAAATTA AAAGGCTTAA -158 
-126 
CCCCCCATCC CTAAAACACA -108 
TCTTGGGGAG GAGCTTATGT  -58 
TATAAATAGT CAAGGGTGAC  -8 
CAGTGGCAGA AGAACTCCTC  43 
TGCATTGGAG CT  85 
Figure 4. DNA sequence of  the 640-bp fragment. The transcription 
start site is indicated by the number +1 above the A residue. The 
TATAA box is underlined. Putative enhancer elements discussed in 
the text are underscored by double underline and numbered at their 
5' residue. These elements are: an AP-2 site at -126 nt, an immu- 
noglobulin enhancer site at -211 nt, two retinoic acid responsive 
elements at  -280 and  -346 nt,  a homeobox protein  consensus 
DNA binding site at -367 nt, and a core enhancer site (also found 
in the rat al[ll] collagen promoter) at -513 nt. Note that there is 
no proper CCAAT  box within the first 100 bp 5' of the transcription 
start site. These sequence data are available from EMBL/G-enBank/ 
DDBJ under accession number Ll1889. 
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Figure 5. The effects of fragments A and B on the activity of 640 
CAT in CEE The activity of 640 CAT is represented as 100%. The 
presence of either fragment A or fragment B in the 640 CAT con- 
struct results in reductions of CAT activity of ~55-60 %. The pres- 
ence of fragments A and B, in the 640 CAT construct result in a 
>90% reduction in CAT activity when compared to the activity of 
640 CAT. The presence of the unrelated NP fragment in the 640 
CAT construct results in '~85 % of the activity of 640 CAT; this is 
a negligible difference. The negative control CAT vector, pBLCAT3, 
demonstrates •5  % of  the activity produced by 640 CAT. CAT activ- 
ity was calculated  as described  in Materials  and  Methods.  The 
range of values in this experiment was <4 % of the average value 
shown. 
ity in both HC and CEF,  despite the fact that CEF do not 
transcribe the collagen X  gene (Lu Valle et al.,  1989),  we 
performed further transfections with CEF using upstream 
sequences from the chick genomic clone PL1G (Lu Valle et 
al., 1988). A 3,100-bp fragment of upstream sequence (frag- 
ment AB in Fig.  1) was placed 5' of 640 CAT to construct 
AB-640 CAT. In addition,  fragment AB was digested with 
PstI to generate fragments A and B. These fragments were 
each ligated into the 640 CAT plasmid 5' of the 640-bp frag- 
ment to generate A-640 CAT and B-640 CAT. CAT activity 
was assayed in CEF using these three constructs to examine 
their effects on the promoter activity of the 640-bp fragment. 
Fig. 5 shows that the presence of the AB fragment 5' of 640 
was associated with a 90-95 % decrease in CAT activity in 
CEF  when  compared with  the  activity  generated  by the 
transfection with 640 CAT. In contrast, the presence of either 
the A fragment or the B fragment 5' of the 640-bp fragment 
in CAT constructs resulted in a reduction of CAT activity of 
only  50-60%  when  compared  with  that  of  640  CAT. 
pBLCAT3, the promoterless CAT plasmid, was used in this 
experiment as a negative control plasmid. The CAT activity 
generated by AB-640 CAT was approximately equivalent to 
the CAT activity generated by the negative control vector. In 
addition, when constructs containing a 3,300-bp fragment of 
unrelated DNA 5' of 640, NP640 CAT, was transfected into 
CEF,  there was no significant reduction in CAT activity. 
Based on the results described above, different combina- 
tions of 5' flanking fragments were inserted into 640 CAT to 
generate  additional  collagen  X  promoter-CAT constructs 
(ABC-640 CAT and BC-640 CAT; see Fig.  1).  These con- 
struets, as well as 640 CAT, AB-640 CAT, B-640 CAT, and 
C-640 CAT, were transfected into HC, IC, and CEF (Fig. 2, 
a-f).  Transfection  of these  constructs  into  CEF  and  IC 
resulted in significant reductions in CAT activity when com- 
pared to 640 CAT (Fig. 6, a  and b). The presence of frag- 
ment B or C (Fig.  1) in 640 CAT constructs produced a 75 
and  50%  reduction  in  CAT activity,  respectively,  in both 
CEF and IC (Fig.  6, a  and b), while the presence of frag- 
ments AB, BC, or ABC reduced CAT activity by •90  % in 
both cell types. In contrast, transfections of the above con- 
structs into HC resulted in high CAT activity, comparable to 
that resulting from transfection with 640 CAT. Transfections 
using B- or C-640  CAT resulted  in activity equivalent to 
'~90%  of that resulting from transfections with 640 CAT, 
while  transfections  using  BC-  AB-,  or  ABC-640  CAT 
resulted in 75-80%  of the activity seen in cells transfected 
with 640 CAT (Fig.  6  c). 
Discussion 
Multiple Negative Elements Far Upstream of the 
Transcription Start Site Act in Conjunction with 
Elements Close to the Transcription Start to Confer 
Specific Expression on the Collagen X Gene 
The results  presented above indicate that the 4,200-bp  5' 
flanking  fragment of the  chicken collagen X  gene,  when 
present 5' of the 640-bp fragment, is able to restrict the ex- 
pression of the reporter gene CAT to mature hypertrophic 
chondrocytes in culture. We show that the 640-bp fragment, 
which includes the transcription start site, promotes strong 
expression of CAT in IC, HC, and CEE The addition of the 
4,200-bp 5' flanking fragment, ABC, dramatically reduces 
CAT  activity driven  by the  collagen X  promoter in  non- 
collagen X-expressing cells but has no effect on the collagen 
X promoter-driven CAT activity in HC. Although the size of 
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Figure 6.  The effects of fragments A, B, and C on the activity of 
640 CAT in CEF, IC, and HC. (a) The presence of fragments C or 
B in 640 CAT constructs resulted in a reduction of CAT activity to 
,,045 and 25 % of the activity of 640 CAT in CEF, respectively. 
Combinations of fragments A, B, and C, (AB, BC, or ABC) in 640 
CAT constructs reduced CAT activity to ~12% of the activity of 
640 CAT. The range of values for each construct was <2 % of the 
average value for each data point depicted here. (b) The reduction 
of CAT activity in response to the presence of fragments B or C 
in 640 CAT constructs in IC is '~40 and 23 % of 640 CAT, respec- 
tively. Combinations of fragments A, B, and C, result in reductions 
equivalent to 10-15  % of that resulting from 640 CAT. The range 
of values for each construct was <2% of the average value of each 
the DNA fragment 5' of the collagen X promoter fragment 
640 did not affect promoter activity in HC, we tested this in 
CEF to eliminate the possibility that the large size of the 5' 
flanking fragment, rather than silencer elements within the 
fragment, was responsible for inhibiting the activity of the 
promoter. The addition of a 3,300-bp fragment of unrelated 
DNA (part of the coding region of a nuclear pore complex 
protein, NP) 5' of 640 in the CAT construct, had no affect 
on  the  strong  promoter activity of the  640-bp  fragment 
alone. Therefore we concluded that the effect of the collagen 
X gene fragment on the activity of the collagen X promoter 
in these constructs was due to specific sequence elements 
contained  within  the  gene  fragment,  not  because  of  a 
nonspecific effect due to its size. These data strongly suggest 
that the presence of the ABC fragment is required for the 
cell-specific CAT activity demonstrated herein, and there- 
fore that this fragment may be instrumental in limiting colla- 
gen X gene expression to hypertrophic chondrocytes during 
endochondral ossification. 
Negative regulatory elements have been identified in a va- 
riety of tissue-specific and developmentally regulated genes, 
such as the rat skeletal myosin heavy chain gene (Bouvagnet 
et al., 1987), the rat prolactin gene (Zhang et al., 1990), the 
mouse od(I) collagen gene (Karsenty and de Crombrugghe, 
1990;  Ravazzolo et al.,  1991),  and the rat ¢xl(II) collagen 
gene (Savagner et al., 1990). For example, in the otl(I) colla- 
gen gene, two negative factors and a positive factor interact 
with DNA sequences between bases -222 and -80, and the 
binding of  one of  the negative factors is inhibited by the pres- 
ence of the positive factor (Karsenty and de Crombrugghe, 
1990). In addition, the otl(I) collagen gene contains an up- 
stream sequence between  -361  and  -339 which exhibits 
strong negative activity in fibroblasts but not other cell types 
(Ravazzolo et al.,  1991).  The rat od(II) collagen gene con- 
tains  two  silencer  elements  located  between  -700  and 
-620,  and  -460 and  -360; the silencers act together to 
significantly reduce promoter activity in fibroblasts, but not 
chondrocytes  (Savagner  et  al.,  1990).  Since  these  two 
silencers confer tissue specificity on the type II collagen pro- 
moter, it is possible that the collagen II gene shares some 
regulatory mechanisms with the collagen X gene. 
The three subfragments used independently in CAT con- 
structs in the presence of the 640-bp fragment each act to 
partially repress the promoter activity of the 640-bp frag- 
ment in non-collagen X-expressing cells. Our data indicate 
that fragments A and B have a stronger effect than fragment 
C  in this regard. In addition, fragment AB, BC, and ABC 
are more efficient at repressing CAT activity in 640 CAT than 
fragment A, B, or C  alone. These results suggest that the 
repressor effect is additive, and in this regard is similar to 
the effect of the two silencers found in the 5' flanking region 
of the collagen II gene (Savagner et al., 1990). Since the ac- 
tivity of the  CAT constructs containing multiple subfrag- 
merits  is comparable with that of the background activity 
data point depicted here. (c) The same constructs used in transfec- 
tions of CEF and IC were also used to transfect HC. The presence 
of 5' flanking fragments A, B, and C singly and in combination in 
640-bp constructs resulted in reductions in CAT activity ranging 
from less than 10% (fragments B or C) to 20-25 % (fragments AB, 
BC, and ABC) of that of 640 CAT. The range of values for each 
construct was <5% of  the average value of  each data point depicted 
here. 
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it is possible that the additive effect of these subfragments is 
sufficient to effectively silence the collagen X gene promoter 
in inappropriate cell types (i.e., IC and CEF). Our observa- 
tion that silencing of this promoter requires several relatively 
weak elements spread diffusely over 4,200 bp of DNA, rather 
than one strong element, implies that this is a somewhat novel 
transcriptional  regulatory mechanism.  We are currently in 
the process of defining these regulatory elements and identi- 
fying their specific DNA binding proteins. 
The potential problems surrounding  the analysis of data 
generated from transient transfection assays are well known. 
Firstly, the DNA does not incorporate itself into the genome, 
therefore it is essentially naked, and unmodified. In contrast, 
genomic DNA contains chromatin, and is in a physical state 
such that its conformation may either allow or inhibit regula- 
tory proteins from binding. In addition, various minor experi- 
mental variables can affect reporter gene activity resulting 
from transient transfections (Everett,  1988). The advantage 
is that it is an efficient and relatively inexpensive technique 
which is widely accepted. Nevertheless, promoter specificity 
should ideally be confirmed in an in vivo system where all 
possible regulatory influences are present, such as in a trans- 
genie animal. 
Recently, we have produced transgenic mice that carry a 
gene construct  consisting  of the chicken collagen X  gene 
promoter and cell-specific repressor fragments  fused to a 
full-length chicken collagen X eDNA containing an in-frame 
deletion in the triple helical-coding domain. The phenotype 
of these mice is characterized by a dramatic compression of 
the hypertrophic zone of skeletal elements undergoing endo- 
chondral ossification, as well as a reduction in bony trabec- 
ulae.  Expression of the chicken collagen X  transgene,  de- 
tected by immunoreactivity to a mAb against chicken, but 
not mouse, collagen X, is limited to the abbreviated area of 
hypertrophic chondrocytes within the growth plates of the 
transgenic mice (Jacenko, O., P. Lu Valle,  and B. R. Olsen, 
manuscript submitted for publication). These results strongly 
suggest that the negative regulatory elements in the upstream 
collagen X  fragments are able to restrict expression of the 
gene to hypertrophic chondrocytes in vivo. They also imply 
that our data generated by reporter gene assays in cultured 
ceils reflect the hypertrophic  chondrocyte-specific mecha- 
nisms of collagen X gene expression operating in vivo. Fu- 
ture studies will involve examining the effect of inappropriate 
collagen X expression in transgenic mice by injection of a 
collagen X transgene driven by the nonspecific 640-bp por- 
tion of the chicken collagen X promoter, as well as transgenic 
experiments involving the inactivation of different areas of 
the endogenous mouse promoter. 
The Collagen X Promoter Contains Strong 
Positive Element(s) within 550 bp Upstream of the 
Transcription Start Site 
Sequences within the 640-bp fragment of the chicken colla- 
gen X gene, which includes the transcription  start site, are 
sufficient to promote strong expression of the reporter gene 
CAT in CEF, IC, and HC relative to the expression generated 
by constructs containing  repressor fragments.  The expres- 
sion of CAT in response to the presence of the 640-bp frag- 
ment and measured as acetylation activity is equivalent to or 
greater than CAT expression driven by the HSV thymidine 
kinase promoter in both HC and CEF.  These data suggest 
that the non-cell specific collagen X gene promoter activity 
shown here is the result of nonspecific upstream activator se- 
quences within the 640-bp fragment. The comparison of the 
sequence of this fragment with defined regulatory consensus 
sequences,  as  shown  above,  suggests  that  enhancer  ele- 
ment(s) might be acting either singly or together to provide 
such promoter activity in the 640-bp fragment. Interestingly, 
this fragment has two features in common with the collagen 
II gene promoter:  the presence in both of a core enhancer 
consensus sequence,  and the absence in both of a proper 
CCAAT box within 100 bases of the transcription  start site 
(Kohno et al., 1985). The presence of the homeobox protein 
DNA binding site consensus sequence at -367 nt may have 
significance,  since  homeobox  proteins  which  potentially 
recognize this sequence (yeast MAT o.2, and the human oct-2 
gene produc0 are gene regulatory proteins (Ko et al., 1988). 
The sequences resembling retinoic acid responsive elements 
located at -346 nt and -280 nt may be functional, since we 
have shown that retinoic acid treatment of cultured caudal 
embryonic sternal chondrocytes causes induction of collagen 
X gene expression (Oettinger and Pacifici,  1990; Pacifici et 
al.,  1991b).  The immunoglobulin  enhancer  binding  motif 
(Maeda et al.,  1987) found at -211 nt can act as a binding 
site for two enhancer proteins; one is found in all cell types, 
while the other is present only in lymphoid cells (Staudt et 
al., 1986). This site may also be a variant of the site at -367, 
since the oct 2 gene product apparently encodes NF-A2, the 
lymphoid-specific protein (Ko et al.,  1988). The consensus 
DNA binding site at -126 nt is recognized by the enhancer 
binding protein, AP-2. This protein can mediate gene tran- 
scription by means of signal transduction pathways involving 
either protein kinase C or cAMP-dependent protein kinase 
A 0magawa et al., 1987). Currently, we are testing the possi- 
bility that these elements and/or other unidentified elements 
are active in either enhancing collagen X gene expression or 
mediating its repression by performing DNA binding studies 
using nuclear extracts with defined sequence elements within 
the 640-bp fragment. 
Some collagen genes, including the od(I) gene (Hartung et 
al.,  1986),  the  ot2(I)  gene  (Rossi  and  de  Crombrugghe, 
1987),  od(II)  gene  (Lovell-Badge,  1987;  Horton  et  al., 
1987), and the od0V) gene (Burbello et al., 1991), have been 
found to contain elements with enhancer activity in the first 
intron.  Our results using constructs containing the first in- 
tron in addition to the 640-bp fragment do not demonstrate 
activity in significant  excess of that seen with the 640-bp 
fragment alone (data not shown). This does not exclude the 
possibility that enhancer activity within the first intron of the 
collagen X gene is present, but not detectable by our in vitro 
assay system. 
Taken together,  the results  of this  investigation  demon- 
strate that the 4,200-bp 5' flanking fragment (fragment ABC) 
of the chicken collagen X gene, when present 5' of the 640- 
bp promoter fragment in CAT constructs, limits CAT activity 
to mature hypertrophic  chondrocytes. These data strongly 
suggest that the fragment ABC plays an important  role in 
regulating the temporal and spatial expression of the colla- 
gen X gene. It is not yet clear whether a single consensus 
sequence, which would interact with the same DNA binding 
protein, is present multiple times within fragment ABC, or 
if  several  DNA  binding  proteins  recognizing  unique  se- 
quences spread diffusely throughout fragment ABC act to- 
gether to confer cellular specificity on the collagen X gene 
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fragments A, B, and C suggest that the latter may be the case. 
Mobility  shift assays  using nuclear  extracts  from collagen 
X-expressing and -nonexpressing cells, as well as competi- 
tion experiments  involving binding between defined proteins 
and DNA sequence will provide more specific  information 
about the mechanisms involved in the repression-mediated 
cell-specific transcription  of the collagen X  gene. 
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